高级检索

人工智能在抗癌肽研发中的应用与挑战

Applications and challenges of artificial intelligence in the development of anticancer peptides

  • 摘要: 抗癌肽(anticancer peptides,ACPs)因其高效低毒和高选择性优势成为研究焦点,而基于人工智能的ACPs识别和设计方法较传统实验方法成本低廉、成功率高且能够探索更广阔的序列空间。本文重点介绍了人工智能技术在ACPs生成和识别过程中的应用,包括深度生成模型探索新型ACPs设计以及基于机器学习和深度学习的ACPs识别方法。此外,文章还讨论了当前研究中存在的模型可复现性和可解释性不足、缺乏经过实验验证的阴性数据等挑战,并对未来研究方向提出展望,以期为ACPs的研发提供新思路。

     

    Abstract: Anticancer peptides (ACPs) have become a focal point of research due to their high efficacy, low toxicity, and high selectivity. Methods of ACP identification and design based on artificial intelligence (AI) surpass traditional experimental techniques in cost-efficiency, success rate, and the ability to investigate a broader sequence space. This article highlights the application of AI technology in the generation and identification of ACPs, including the exploration of new ACP design through deep generative models and ACP identification methods based on machine learning and deep learning. Furthermore, it discusses challenges in current research, such as insufficient model reproducibility and interpretability, and a lack of experimentally validated negative data. Future research directions are proposed to provide new insights for the development of anticancer peptides, aiming to enhance the understanding and development of ACPs.

     

/

返回文章
返回